Bayer Aktiengesellschaft (BAYRY)
Makes medicines, health products, and crop protection chemicals for people and farms worldwide.
$13.45+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+66.3%
The outlook
BAYRY is trading above both its 50- and 200-day moving averages, positioning it in the upper half of its 52-week range. Analyst sentiment leans bullish with a buy consensus, and the average price target sits roughly 13% above the current price. Overall, the data reflects a constructive technical and sentiment backdrop.
What’s behind the score
Analyst consensusBuy — 2.3 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range78% of the way from its 52-week low to high
Price targetAvg target +13% vs current price
Analyst price target
~12-month · 4 analysts$15.23average target+13.2% vs now
Now $13.45
Low $14.50High $15.80
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$52.85B
52-wk high
$15.23
52-wk low
$7.19
50-day avg
$12.03
200-day avg
$11.03
Trailing P/E
—